Lipoprotein lipase (LPL) is a 55 kilo-dalton glycoprotein which hydrolyzes the triglyceride component of circulating chylomicrons and very low density lipoproteins to free fatty acids (1-4). The human LPL gene is assigned to chromosome 8p22 (5) and has a length of 30 kb comprising 10 exons (6, 7). The first nine exons encode a 475-amino acid protein including a 27-amino acid signal peptide (8), while exon 10 encodes the untranslated 3' end of the mRNA. Homozygosity and compound heterozygosity for LPL gene deficiencies cause hyperchylomicronemia, a relatively rare disorder occurring at a frequency of about one in a million, which is often accompanied by pancreatitis and eruptive xanthomas (9). In the last few years, over 30 different mutations which result in defective LPL have been identified.
It has been reported that some heterozygous individuals with a familial LPL defect have hypertriglyceridemia (10-12). Therefore, heterozygosity for LPL defects may be involved in hyperlipoproteinemia such as type IIb, IV or V. We examined the LPL gene in patients with hypertriglyceridemia to screen for novel mutations and to study whether an abnormal LPL gene is involved in hypertriglyceridemia. Heterozygotes with normal LPL activity or mass in postheparin plasma have been reported (10-12), so we directly studied the LPL gene in patients with hypertriglyceridemia without measuring LPL activity or mass. Most dysfunctional LPL genetic defects reported to date are the result of one point mutation (13). Therefore, we used single-stranded conformation polymorphism (SSCP) analysis, an efficient method for detecting single base differences in polymerase chain reaction (PCR) products (14, 15) , to search for mutations.
Consequently, we found a novel nonsense mutation in exon 1 and a novel single transition in intron 3. We then borate and 1 mM EDTA) with or without glycerol, at 4°C or at room temperature for appropriate periods (70-120 min). The gels were stained with ethidium bromide. Due to the size of exon 6, its PCR product was digested by Hae Ill (Takara Shuzo, Kyoto, Japan) and the digested fragments (123 by and 210 bp) were electrophoresed.
DNA sequence PCR products showing an abnormal pattern were purified by separation on an agarose gel (Ultra Pure Agarose; Life Technologies, Gaithersburg, MD, USA), cutting out the band and extracting the DNA fragment using a commercial kit (GENE CLEAN2 ; Bio 101, Lajolla, CA, USA). The purified DNA fragment was directly sequenced using a CircumVentTM Thermal Cycle Dideoxy DNA Sequencing Kit (New England Biolabs, Beverly, MA, USA).
The 690 by 5' flanking region from the ATG initiation codon of the LPL gene was amplified by PCR with primers PF5 and PF3 as shown in Table 1 , and its sequence was determined by the same method as described above. to dishes were harvested for as a source of mRNA. Total RNA was isolated using TRIzol' solution (Life Technologies, Gaithersburg, MD, USA) and 0.5 ,ug aliquots of RNA were reverse transcribed using RNA buffer (10 mM Tris-HCI, 50 mM KCI, pH 8), dNTPs mixture (1 mM), RNase inhibitor (1 Uint/ primer (Table 1, RT2 ). Then, PCR was performed with Taq DNA polymerase and 5' primer (Table 1, RT1) , and the PCR product between exon 2 and exon 5 was obtained. This sample was developed on a 2% agarose gel.
PCR-RFLP

LPL mass
The LPL mass of post-heparin plasma was determined in some patients with LPL gene abnormality. After fasting for over 12 hours, plasma samples were obtained 10 min after the injection of heparin (Novo Industry, A/S, Denmark) at a dose of 30 IU/kg body weight. LPL mass was measured using an ELISA kit (MARKIT®-FLPL ; Dainippon Pharmaceutical CO., Osaka, Japan) (18).
Results
SSCP
The PCR product of exon 1 from one patient and PCR products of exon 4 from 5 patients showed abnormal patterns on SSCP gels (Figs. 3 and 4) . The PCR products of exon 9 from 3 patients also revealed abnormal patterns (not shown). The PCR products of exon 1 from normal controls after PshAl digestion yielded one 140 by band. On the other hand, the product from the patient with abnormal SSCP pattern yielded one band of 113 by and another fragment of 27 by which was not clearly detected on the gel (Fig. 1B) . The PCR product of her heterozygous daughter, yielded two bands of 140 by and 113 bp.
The homozygous proband, was a 74-year-old woman who was hospitalized for syncope. She was not suffering from pancreatitis or ischemic heart disease.
Her maximum plasma triglyceride level was 1,639 mg/dl and her ordinary triglyceride levels were approximately 800 mg/dl. Lipoprotein electrophoretogram showed increased chylomicrons. LPL protein was not detected in her post-heparin plasma. The LPL gene of her husband was normal. Four of the proband's five children were examined. They were heterozygous for the mutation and their plasma triglyceride levels were entirely normal. Among 3 children in whom LPL mass was examined in post-heparin plasma, two had normal LPL mass, while one demonstrated the lower limit ( Table 2 ). The children manifested no obesity, diabetes mellitus nor habitual alcohol drinking behavior. They mainly ate vegetables and fish.
RFLP analysis revealed no case with this nonsense mutant among the other hypertriglyceridemic patients or 105 normolipidemic control subjects.
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The PCR product of exon 4 from normal controls after 
